Velleca Mark A.
SEC insider (Form 3/4/5 filer). CIK 0001706847. PRESIDENT & CEO at Black Diamond Therapeutics, Inc. (BDTX). 2 reported Form 4/5 transactions since Sep 2024; latest on Jan 21, 2026. Located in CAMBRIDGE, MA.
Companies Velleca Mark A. has filed insider reports for
- Black Diamond Therapeutics, Inc. (BDTX): Director, Officer, PRESIDENT & CEO
Velleca Mark A.
CIK: 0001706847
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BDTX
Black Diamond Therapeutics, Inc.
DirectorOfficer